
Maria Cabanillas, MD
@drmcabanillas
Oncologic endocrinologist @MDAndersonNews Treats papillary, anaplastic, & medullary #thyroidcancer. Director Clinical Research Endocrine Neoplasia.Tweets=my own
ID: 817762562444001280
http://bit.ly/2jb2JEi 07-01-2017 15:59:22
96 Tweet
590 Followers
97 Following

Loxo-292 Outstanding responses in RET altered tumors Alexander Drilon MD Vivek Subbiah, MD @sloan_kettering MD Anderson Cancer Center Cleveland Clinic MD- a potentially exciting new option for patients with RET altered MTC and lung cancers #LCSM #ASCO18


Working toward same goal: making anaplastic thyroid cancer history. Facilitating Anaplastic Thyroid Cancer Specialized Treatment Team (FAST) MD Anderson Cancer Center Maria Cabanillas, MD Mark Zafereo, MD Neil D. Gross, MD, FACS Naifa Busaidy Maria Gule-Monroe MD Heath Skinner, MD PhD x.com/sitcancer/stat…

New hope for patients with Anaplastic #ThyroidCancer Neoadjuvant therapy followed by surgical resection for BRAF-mutated Anaplastic #ThyroidCancer at #ATAthyroid2018 American Thyroid Association MD Anderson Cancer Center @PhysRelations ThyCa Inc. ETC Thyroid Patients ThyroidChange


Congratulations to Judy Qin, my research fellow at MDA, for winning the clinical poster award at #ATAThyroid2018 Ramona Dadu, MD Naifa Busaidy Mark Zafereo, MD Steven I. Sherman, M.D. Steven Weitzman, MD


Anaplastic Thyroid Cancer Trials at MD Anderson Cancer Center: New Frontiers and Hope Thyroid Federation ThyCa Inc. Thyroid Patients ThyroidChange ETC BTF Thyroid Thyroid NZ


Dr. Camilo Jiménez discussing cabozantinib in malignant pheo and paraganglioma at GAP meeting MD Anderson Cancer Center


Dr Jaber discussing MEK&BRAF inhibitors 2 restore RAI uptake in #thyroidcancer MD Anderson Cancer Center GAP conf. Nice work!


Endocrine fellows representing us well!! Dr Iyer discusses targeted tx 4 anaplastic #thyroidcancer MD Anderson Cancer Center


We're excited 2 have Dr. Erich Sturgis (of MD Anderson Cancer Center) & Camille Meyer sharing how 2 lower risk of #endometrialcancers on SiriusXM



Unsustainable trend. Time to address the elephant in the room MOC Brasil #MOCnaASCO x.com/vinayprasad82/…


Early access to v promising drug for TRK fusion cancer w landmark trial by David S. Hong MD!! MD Anderson Cancer Center @PhysRelations #ASCO17 #endcancer x.com/davidhongmd/st…

A second opinion brings light to a #thyroidcancer survivor’s health mystery bit.ly/2uu89U3 Maria Cabanillas, MD Mark Zafereo, MD #endcancer




Worst behaved table at #ITOG2018. Julie A Sosa, MD Maria Cabanillas, MD Naifa Busaidy @drgrubbsmdacc American Thyroid Association ThyCa Inc.
